Evidence map›Paper›PMID 21055985›Full record

ArticleMolecular cell2010

A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability.

Brenda C O'Connell, Britt Adamson, John R Lydeard, Mathew E Sowa, Alberto Ciccia, Andrea L Bredemeyer, Michael Schlabach, Steven P Gygi, Stephen J Elledge, J Wade Harper

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Brenda C O'ConnellDepartment of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Britt Adamson
John R Lydeard
Mathew E Sowa
Alberto Ciccia
Andrea L Bredemeyer
Michael Schlabach
Steven P Gygi
Stephen J Elledge
J Wade Harper
Brigham and Women's Hospital · USHarvard University · US

Funding

Ubiquitin Mediated Proteolysis and Cell Cycle ControlR01AG011085 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JEFFREY W HARPER · 1993 to 2026
$10.9M
SYSTEMATIC ANALYSIS OF THE DUB PROTEOMER01GM054137 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HARPER, JEFFREY W · 1996 to 2012
$4.1M
SYSTEMATIC ANALYSIS OF PROTEOLYSIS PATHWAYS FOR CULLIN TARGETSR01GM070565 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI HARPER, JEFFREY W · 2005 to 2012
$2.6M
Howard Hughes Medical InstituteNIA NIH HHS AG011085NIA NIH HHS R01 AG011085NIGMS NIH HHS GM054137NIGMS NIH HHS R01 GM054137NIGMS NIH HHS R01 GM070565
6 · The paper itself

Abstract

Replication stress involving collision of replisomes with camptothecin (CPT)-stabilized DNA-Topoisomerase I adducts activates an ATR-dependent pathway to promote repair by homologous recombination. To identify human genes that protect cells from such replication stress, we performed a genome-wide CPT sensitivity screen. Among numerous candidate genes are two previously unstudied proteins: the ankyrin repeat protein NFKBIL2 and C6ORF167 (MMS22L), distantly related to yeast replication stress regulator Mms22p. MMS22L and NFKBIL2 interact with each other and with FACT (facilitator of chromatin transcription) and MCM (minichromosome maintenance) complexes. Cells depleted of NFKBIL2 or MMS22L are sensitive to DNA-damaging agents, load phosphorylated RPA onto chromatin in a CTIP-dependent manner, activate the ATR/ATRIP-CHK1 and double-strand break repair signaling pathways, and are defective in HR. This study identifies MMS22L-NFKBIL2 as components of the replication stress control pathway and provides a resource for discovery of additional components of this pathway.

Indexed as

Genetic TestingCamptothecinDNA-Binding ProteinsDNA DamageDNA-Directed DNA PolymeraseDNA RepairDNA ReplicationDrug Resistance, NeoplasmGenome, HumanGenomic InstabilityHeLa CellsHistonesHumansIntracellular Signaling Peptides and ProteinsMultienzyme ComplexesNF-kappa BCamptothecinDNA-Binding ProteinsDNA-Directed DNA PolymeraseH2AX protein, humanHistonesIntracellular Signaling Peptides and ProteinsMMS22L protein, humanMultienzyme ComplexesNF-kappa BNuclear ProteinsReplication Protein AReplisomesRNA, Small InterferingRPA2 protein, humanTONSL protein, humanTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1

Identifiers

PMID21055985
PMCPMC3006237
OpenAlexW2005855776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.